中国医学创新2025，Vol.22Issue(4)：173-178,6.DOI:10.3969/j.issn.1674-4985.2025.04.040
代谢相关脂肪性肝病相关性肝硬化的研究进展
Research Progress of Cirrhosis Associated with Metabolic Associated Fatty Liver Disease
王花花 1孙丽华1
作者信息
- 1. 新疆医科大学第一附属医院肝病中心 新疆 乌鲁木齐 830054
- 折叠
摘要
Abstract
With the wide use of hepatitis B vaccine and the development of antiviral drugs,the incidence of viral hepatitis has decreased significantly,while the incidence of metabolic liver disease has increased year by year.Metabolic liver disease can lead to liver fibrosis,cirrhosis and even liver cancer,which is a serious threat to human health.At present,cirrhosis is the biggest threat of this disease,and there are few studies on this disease in the cirrhosis stage.Therefore,studying the diagnosis and treatment of this disease in the cirrhosis stage is crucial for the classification and management of this disease,improving the prognosis,and reducing the morbidity and mortality.In this paper,the renaming,diagnosis and treatment of metabolic associated fatty liver disease(MAFLD)associated cirrhosis are reviewed,so as to provide reference for future clinical research and drug administration.关键词
代谢相关脂肪性肝病/肝硬化/诊断/治疗Key words
Metabolic associated fatty liver disease/Cirrhosis/Diagnosis/Treatment引用本文复制引用
王花花,孙丽华..代谢相关脂肪性肝病相关性肝硬化的研究进展[J].中国医学创新,2025,22(4):173-178,6.
